Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – 8 February 2021 :: Interim recommendations for use of the AZD1222 (‎ChAdOx1-S [‎recombinant]‎)‎ vaccine against COVID19 developed by Oxford University and AstraZeneca: interim guidance, 10 February 2021

Milestones :: Perspectives :: Research

 

Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – 8 February 2021
Meeting materials
:: Final Agenda
Background documents
:: Background document on the Astra Zeneca – Oxford University AZD1222 vaccine against COVID-19 (Draft)
Presentations
:: Update on recent developments including on COVAX
K. O’Brien, pdf, 4.4Mb
:: AstraZeneca COVID-19 Vaccine Update
J. Vekemans. pdf, 4.6Mb
:: Assessment of the critical evidence, including data and draft recommendations related to vaccine use in older adults
SAGE Working Group. pdf, 3.2Mb
:: Emerging data on the use of AZD1222 in the context of new virus variants
A. Pollard & S. Madhi. pdf, 370Kb

 

Interim WHO recommendations
Interim recommendations for use of the AZD1222 (‎ChAdOx1-S [‎recombinant]‎)‎ vaccine against COVID19 developed by Oxford University and AstraZeneca: interim guidance, 10 February 2021
World Health Organization. https://apps.who.int/iris/handle/10665/339477. License: CC BY-NC-SA 3.0 IGO :: 7 pages
…These interim recommendations apply to AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University (United Kingdom) and AstraZeneca as well as to ChAdOx1-S [recombinant] vaccines against COVID-19 produced by other manufacturers that rely on the AstraZeneca core clinical data, following demonstrated equivalence in their regulatory review and once emergency use listing (EUL) has been obtained from WHO.The guidance is based on the evidence summarized in the Background document on AZD1222 vaccine against COVID-19 developed by Oxford University and AstraZenecaand the Background paper on COVID-19 disease and vaccines. Both these documents are available on the SAGE COVID-19 webpage: https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization/covid-19-materials